[Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?]

[Article in Japanese]

Affiliations

Review

[Article in Japanese]

H Harada et al. Nihon Rinsho. 1995 Sep.

. 1995 Sep;53 Suppl(Pt 1):754-8.

No abstract available

Similar articles

[Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
Yoshida H, Omata M. Yoshida H, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):463-6. Nihon Rinsho. 2004. PMID: 15359842 Review. Japanese. No abstract available.
[Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Takemura S, Shiomi S, Kinoshita H. Kubo S, et al. Gan To Kagaku Ryoho. 2001 Dec;28(13):1975-9. Gan To Kagaku Ryoho. 2001. PMID: 11791377 Review. Japanese.
[Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
Nishiguchi S, Kubo S, Shiomi S. Nishiguchi S, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):600-4. Nihon Rinsho. 2004. PMID: 15359868 Review. Japanese. No abstract available.
Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis.
Testino G, Ansaldi F, Andorno E, Ravetti GL, Ferro C, De Iaco F, Icardi G, Valente U. Testino G, et al. Hepatogastroenterology. 2002 Nov-Dec;49(48):1636-8. Hepatogastroenterology. 2002. PMID: 12397752
[Management of HCV cirrhosis in patients awaiting liver transplantation and prevention of hepatocellular carcinoma].
Testino G. Testino G. Recenti Prog Med. 2007 Apr;98(4):252-8. Recenti Prog Med. 2007. PMID: 17547364 Review. Italian.